191 related articles for article (PubMed ID: 9971764)
1. Multiple functions for the basic amino acids of the human T-cell leukemia virus type 1 matrix protein in viral transmission.
Le Blanc I; Rosenberg AR; Dokhélar MC
J Virol; 1999 Mar; 73(3):1860-7. PubMed ID: 9971764
[TBL] [Abstract][Full Text] [Related]
2. Both the PPPY and PTAP motifs are involved in human T-cell leukemia virus type 1 particle release.
Wang H; Machesky NJ; Mansky LM
J Virol; 2004 Feb; 78(3):1503-12. PubMed ID: 14722305
[TBL] [Abstract][Full Text] [Related]
3. Role of the human T-cell leukemia virus type 1 PTAP motif in Gag targeting and particle release.
Dorweiler IJ; Ruone SJ; Wang H; Burry RW; Mansky LM
J Virol; 2006 Apr; 80(7):3634-43. PubMed ID: 16537631
[TBL] [Abstract][Full Text] [Related]
4. Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.
Kiernan RE; Ono A; Freed EO
J Virol; 1999 Jun; 73(6):4728-37. PubMed ID: 10233933
[TBL] [Abstract][Full Text] [Related]
5. Critical Role of the Human T-Cell Leukemia Virus Type 1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly.
Martin JL; Mendonça LM; Marusinec R; Zuczek J; Angert I; Blower RJ; Mueller JD; Perilla JR; Zhang W; Mansky LM
J Virol; 2018 Jul; 92(14):. PubMed ID: 29695435
[TBL] [Abstract][Full Text] [Related]
6. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
Kiernan RE; Ono A; Englund G; Freed EO
J Virol; 1998 May; 72(5):4116-26. PubMed ID: 9557701
[TBL] [Abstract][Full Text] [Related]
7. Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.
Dettenhofer M; Yu XF
J Virol; 1999 Jun; 73(6):4696-704. PubMed ID: 10233929
[TBL] [Abstract][Full Text] [Related]
8. A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity.
Delamarre L; Rosenberg AR; Pique C; Pham D; Dokhélar MC
J Virol; 1997 Jan; 71(1):259-66. PubMed ID: 8985345
[TBL] [Abstract][Full Text] [Related]
9. Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag.
Inlora J; Chukkapalli V; Derse D; Ono A
J Virol; 2011 Apr; 85(8):3802-10. PubMed ID: 21289126
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the matrix and nucleocapsid domains of the bovine leukemia virus Gag polyprotein precursor in viral RNA packaging.
Wang H; Norris KM; Mansky LM
J Virol; 2003 Sep; 77(17):9431-8. PubMed ID: 12915558
[TBL] [Abstract][Full Text] [Related]
11. Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release.
Heidecker G; Lloyd PA; Fox K; Nagashima K; Derse D
J Virol; 2004 Jun; 78(12):6636-48. PubMed ID: 15163754
[TBL] [Abstract][Full Text] [Related]
12. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor.
González SA; Affranchino JL
Virology; 1998 Jan; 240(1):27-35. PubMed ID: 9448686
[TBL] [Abstract][Full Text] [Related]
13. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein.
Manrique JM; Celma CC; Hunter E; Affranchino JL; González SA
J Virol; 2003 Oct; 77(20):10881-8. PubMed ID: 14512538
[TBL] [Abstract][Full Text] [Related]
14. A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent manner.
Lee YM; Tian CJ; Yu XF
J Virol; 1998 Nov; 72(11):9061-8. PubMed ID: 9765451
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein.
González SA; Affranchino JL
Virology; 1995 Jul; 210(2):501-7. PubMed ID: 7618287
[TBL] [Abstract][Full Text] [Related]
17. New insights into HTLV-1 particle structure, assembly, and Gag-Gag interactions in living cells.
Fogarty KH; Zhang W; Grigsby IF; Johnson JL; Chen Y; Mueller JD; Mansky LM
Viruses; 2011 Jun; 3(6):770-93. PubMed ID: 21994753
[TBL] [Abstract][Full Text] [Related]
18. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
Ono A; Orenstein JM; Freed EO
J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
[TBL] [Abstract][Full Text] [Related]
19. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
Freed EO; Martin MA
J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546
[TBL] [Abstract][Full Text] [Related]
20. Mutagenesis analysis of the murine leukemia virus matrix protein: identification of regions important for membrane localization and intracellular transport.
Soneoka Y; Kingsman SM; Kingsman AJ
J Virol; 1997 Jul; 71(7):5549-59. PubMed ID: 9188629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
